Electromedical Technologies

Electromedical Technologies EBITDA per Share

EBITDA per Share of Electromedical Technologies (EMED) as of Nov 2, 2026.

EBITDA per Share

-0.00USD

YoY

-75.82%

Last updated:

EBITDA per Share of Electromedical Technologies is 2025 -0.00 USD. EBITDA per Share of Electromedical Technologies was 2024 -0.00 USD. It decreases by -75.82% higher compared to the previous year.

The Electromedical Technologies EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-0.02 USD
Jan 1, 2019
-0.10 USD
Jan 1, 2020
-0.14 USD
Jan 1, 2021
-0.07 USD
Jan 1, 2022
-0.01 USD
Jan 1, 2023
-0.00 USD
Jan 1, 2024
-0.00 USD
Jan 1, 2025
-0.00 USD
The Electromedical Technologies EBITDA per Share history
YEAREBITDA per ShareYoY
-0.00USD-75.82%
-0.00USD-74.66%
-0.00USD-46.64%
-0.01USD-88.01%
-0.07USD-51.65%
-0.14USD+43.72%
-0.10USD+448.70%
-0.02USD-40.12%
-0.03USD+220.12%
-0.01USD-35.13%
-0.01USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Electromedical Technologies Stock analysis

What does Electromedical Technologies do? Electromedical Technologies, Inc. generates revenue through the sale of medical devices for pain management, specifically targeting consumers and healthcare professionals. The company's primary products include WellnessPro Plus, WellnessPro POD, and Wellness ION Pen, which utilize bioelectronics and electrical impulses to alleviate pain without drugs. WellnessPro Plus functions as a prescription device that mimics the body's electric signals with micro-current stimulation, while the Wellness ION Pen delivers targeted frequency stimulation via interferential cold laser technology. These products are designed for both consumer and professional use in chronic and acute pain relief. The company focuses on developing electronic medicine solutions that combine micro-stimulation with expanded wavelength capabilities, particularly through the Wellness ION Pen, which is intended for over-the-counter sales. WellnessPro POD is part of the product lineup but lacks detailed description in the business description. The target segments are consumers seeking non-drug pain relief and healthcare professionals who prescribe or recommend these devices for pain management. Electromedical Technologies, Inc. markets its products under the WellnessPro and Wellness ION Pen brand names, emphasizing their unique bioelectronics approach. The company's revenue streams are derived from direct sales of these devices, with WellnessPro Plus positioned as an intelligent therapy device for both home and clinical use. The Wellness ION Pen's over-the-counter availability expands its market reach to general consumers who prefer non-prescription pain management solutions. Electromedical Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Electromedical Technologies stock

On Eulerpool you can find the complete historical development of EBITDA per Share Electromedical Technologies since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Electromedical Technologies

All Key Metrics — Electromedical Technologies